Both in Pharmaceuticals
Minerva Neurosciences vs Nkarta
Over the past year NERV returned −37.7% and NKTX returned −25.4%; their daily moves had a correlation of 0.20.
NERV −37.7% NKTX −25.4%Growth of $1, one year, split-adjusted
| Metric | NERV | NKTX |
|---|---|---|
| Price | $2.38 | $1.55 |
| Market cap | $113.6M | $110.7M |
| Today | +1.49% | +1.64% |
| 1 month | −28.3% | −38.9% |
| 6 months | −61.9% | −49.8% |
| Year to date | −40.8% | −16.5% |
| 1 year | −43.3% | −26.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $75.3M | $182.8M |
| Dividend yield | — | — |
| Volatility (60d) | 78.2% | 61.2% |
| Short % of float | 6.0% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).